Metlen Energy & Metals PLC has announced the issuance of 403,264 new ordinary shares, each with a nominal value of €1.00, which will begin trading on June 23, 2026, simultaneously on the London Stock Exchange and Euronext Athens. These shares were issued through a cash capital increase and will be distributed free of charge to 76 selected executives and employees of the company or its subsidiaries, via a dedicated Employee Benefit Trust (EBT) as part of a stock award incentive program. Following the completion of this process, Metlen’s total share capital now stands at €143,426,244, divided into an equal number of ordinary shares.
Metlen’s official announcement in full
METLEN ENERGY & METALS PLC (the “Company”) hereby informs the investing public, in accordance with the provisions of Article 1(4)(i) and Article 1(5)(h) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, as amended, in connection with the admission to trading on the Main Market of the London Stock Exchange plc (“LSE”) (the “London Admission”) and the secondary admission to trading on Euronext Athens Holding SA (“Euronext Athens” / formerly the Athens Stock Exchange) (the “Euronext Athens Admission” and, together with the London Admission, the “Admission”), of four hundred and three thousand two hundred and sixty-four (403,264) new ordinary registered shares of the Company, each with a nominal value of one euro (€1.00) (the “New Ordinary Shares”), to selected employees and members of the Board of Directors of the Company and its subsidiaries (the “Beneficiaries”).
The New Ordinary Shares will be issued in the context of implementing the stock award program approved by the Board of Directors meeting of June 24, 2025 (the “Stock Award Program”), which constitutes a share-based incentive scheme for the benefit of selected employees and senior executives of the Company and its subsidiaries.
The New Ordinary Shares will be allocated to the Beneficiaries of the Stock Award Program through an Employee Benefit Trust (“EBT”) structure, which operates alongside the Stock Award Program as the implementation vehicle.
The purpose of the Stock Award Program is to reward the performance and contribution of the Beneficiaries toward achieving the Company’s strategic objectives, as well as to enhance the retention, motivation, and attraction of talented and capable executives, thereby serving and safeguarding the long-term interests and sustainability of the Company and its affiliated entities.
The New Ordinary Shares were issued through a cash capital increase approved by a resolution of the Company’s Board of Directors dated June 16, 2026, following a corresponding resolution of the Company’s Remuneration Committee dated June 16, 2026, pursuant to which the establishment and funding of the EBT was approved.
The New Ordinary Shares are of the same class and carry the same rights as the Company’s existing ordinary shares, which are already admitted to trading on the LSE and Euronext Athens.
Pursuant to the aforementioned resolution, the New Ordinary Shares will be allocated to a total of 76 Beneficiaries.
Following the above capital increase, the Company’s share capital will amount to one hundred and forty-three million, four hundred and twenty-six thousand, two hundred and forty-four euros (€143,426,244), divided into one hundred and forty-three million, four hundred and twenty-six thousand, two hundred and forty-four (143,426,244) registered shares, each with a nominal value of one euro (€1.00).
The Company will follow the procedure for the admission of the New Ordinary Shares to trading on Euronext Athens, in accordance with the Euronext Athens Rulebook and the relevant decisions of the Euronext Athens Board of Directors.
The opening trading price of the Company’s shares on Euronext Athens on the first day of trading will be determined in accordance with the Euronext Athens Rulebook and Decision No. 26 of the Euronext Athens Board of Directors, as currently in force.
From the commencement date of trading, the New Ordinary Shares will be registered in the records of the Greek Central Securities Depository (ATHEXCSD) and in the accounts maintained by the Beneficiaries in the Euronext Athens Dematerialized Securities System (DSS), in accordance with applicable legislation.
The commencement date of trading of the New Ordinary Shares is set as June 23, 2026. A relevant announcement will be posted on the Euronext Athens website no later than the business day on which trading commences.
Pursuant to Article 1(4)(i) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended, no obligation to publish a prospectus arises in connection with the offer of the New Ordinary Shares, on the grounds that this disclosure document includes information on the number and nature of the securities being offered, as well as the reasons for and details of the offer.
Pursuant to Article 1(5)(h) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended, no obligation to publish a prospectus arises in connection with the admission to trading on a regulated market, on the grounds that the New Ordinary Shares are of the same class as the Company’s shares already admitted to trading on the same regulated market, and this disclosure document includes information on the number and nature of the new shares being admitted to trading, as well as the reasons for and details of the offer.
